World distribution of factor V Leiden mutation [7]

Lancet

Volumn 347, Issue 8993, 1996, Pages 58-59

  de Maat, M P M ^a   Kluft, C ^a   Jespersen, J ^a   Gram, J ^a   Schroder, W ^a   Koessling, M ^a   Wulff, K ^a   Wehnert, M ^a   Herrmann, F H ^a   Fouere, S ^a   Guibal, F ^a   Morel, P ^a   Gou, D ^a   Naipal, A ^a   Reitsma, P H ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

ETHNIC GROUP; GENETIC EPIDEMIOLOGY; HUMAN; LETTER; POINT MUTATION; PRIORITY JOURNAL; ALLELE; EUROPE; GENE FREQUENCY; GENETICS; GERMANY; MUTATION; NOTE; POPULATION GENETICS; THROMBOEMBOLISM; ADULT; ESKIMO; FEMALE; GREENLAND; MALE;

ALLELES; EUROPE; FACTOR V; GENE FREQUENCY; GENETICS, POPULATION; GERMANY; HUMANS; MUTATION; THROMBOEMBOLISM; ADULT; FEMALE; GREENLAND; INUITS; MALE; POINT MUTATION;

EID: 0030031847     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91590-1     Document Type: Letter

References (16)

1. P. Bjerregaard J. Dyerberg Mortality from ischaemic heart disease and cerebrovascular disease in Greenland Int J Epidemiol 17 1988 514 519
2. P. de Knijff Lg Johansen M. Rosseneu Rr Frants J. Jespersen Lm Havekes Lipoprotein profile of a Greenland Inuit population Arterioscler Thrombos 12 1992 1371 1379
3. Rm Bertina Bpc Koeleman T. Koster Mutation in blood coagulation factor V associated with resistance to activated factor V Nature 369 1994 64 67
4. Rm Bertina Bpc Koeleman T. Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
5. T. Koster Fr Rosendaal H. de Fonde E. Briët Jp Vandenbrouke Rm Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study Lancet 342 1993 1503 1506
6. Mb White M. Carvalho D. Derse Sj O'Brien M. Dean Detecting single base substitutions as heteroduplex polymorphisms Genomics 12 1992 301 306
7. A. Tosetto E. Gatto F. Rodeghiero APC resistance (FV Leiden) has a higher prevalence in females. Preliminary results from the Vicenza Thrombophilia and Arteriosclerosis (VITA) project Thromb Haemost 73 1995 1124
8. Fr Rosendaal T. Koster Jp Vandenbrouke High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
9. B. Dahlback Physiological anticoagulation J Clin Invest 94 1994 923 927
10. Ka Hajjar Factor V Leiden: an unselfish gene N Engl J Med 331 1994 1585 1587
11. Js Greengard S. Eichinger Jh Griffin Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg→Gln mutation m the gene for factor V N Engl J Med 331 1994 1559 1561
12. Pm Ridker Ch Hennekens K. Lindpainter Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis m apparently healthy men N Engl J Med 332 1995 912 917
13. Nk Mehra Agm Bouwens A. Naipal R. Rejalingam Asian Indian HLA-DR2, DR4 and DR52 related DR-DQ genotypes analysed by PCR based non-radioactive oligonucleotide typing: unique haplotypes and a novel DR4 subtype Hum Immunol 39 1994 202 210
14. H. Fujimura J. Kambayashi M. Monden H. Kato T. Miyata Coagulation factor V Leiden may have a racial background Thromb Haemostas 74 1995 1379 1380
15. Rm Bertina Bpc Koeleman T. Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
16. Dn Cooper H. Youssoufian The CpG dinucleotide and human genetic disease Hum Genet 78 1988 151 155